Sleeping Beauty - A mouse model for all cancers?

Cancer Letters

Volumn 317, Issue 1, 2012, Pages 1-8

  Howell, Viive M ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Cancer gene discovery; Insertional mutagenesis; Mouse model; Sleeping Beauty; Transposase; Transposon

Indexed keywords

NUCLEOPHOSMIN; TRANSPOSASE;

ARF GENE; BIOINFORMATICS; CANCER MODEL; CARCINOGENESIS; CELL LINEAGE; COPY NUMBER VARIATION; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC ENGINEERING; GENETIC SUSCEPTIBILITY; HETEROZYGOSITY; IMMUNOGENICITY; LONG TERMINAL REPEAT; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PYROSEQUENCING; SHORT SURVEY; SLEEPING BEAUTY; START CODON; T LYMPHOCYTE; TRANSGENE; TRANSLATION INITIATION; TRANSPOSON; TUMOR SUPPRESSOR GENE;

MUS MUSCULUS;

EID: 84856348348     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2011.11.006     Document Type: Review

References (48)

1. Collier L.S., Carlson C.M., Ravimohan S., Dupuy A.J., Largaespada D.A. Cancer gene discovery in solid tumours using transposon-based somatic mutagenesis in the mouse. Nature 2005, 436:272-276.
2. Dupuy A.J., Akagi K., Largaespada D.A., Copeland N.G., Jenkins N.A. Mammalian mutagenesis using a highly mobile somatic Sleeping Beauty transposon system. Nature 2005, 436:221-226.
3. Ivics Z., Hackett P.B., Plasterk R.H., Izsvak Z. Molecular reconstruction of Sleeping Beauty, a Tc1-like transposon from fish, and its transposition in human cells. Cell 1997, 91:501-510.
4. Geurts A.M., Hackett C.S., Bell J.B., Bergemann T.L., Collier L.S., Carlson C.M., Largaespada D.A., Hackett P.B. Structure-based prediction of insertion-site preferences of transposons into chromosomes. Nucleic Acids Res. 2006, 34:2803-2811.
5. Collier L.S., Largaespada D.A. Hopping around the tumor genome: transposons for cancer gene discovery. Cancer Res. 2005, 65:9607-9610.
6. Aronovich E.L., McIvor R.S., Hackett P.B. The Sleeping Beauty transposon system: a non-viral vector for gene therapy. Hum. Mol. Genet. 2011, 20:R14-R20.
7. Belur L.R., Podetz-Pedersen K.M., Sorenson B.S., Hsu A.H., Parker J.B., Carlson C.S., Saltzman D.A., Ramakrishnan S., McIvor R.S. Inhibition of angiogenesis and suppression of colorectal cancer metastatic to the liver using the Sleeping Beauty Transposon System. Mol. Cancer 2011, 10:14.
8. Luo W.Y., Shih Y.S., Hung C.L., Lo K.W., Chiang C.S., Lo W.H., Huang S.F., Wang S.C., Yu C.F., Chien C.H., Hu Y.C. Development of the hybrid Sleeping Beauty-baculovirus vector for sustained gene expression and cancer therapy. Gene. Ther. 2011.
9. Hackett P.B., Largaespada D.A., Cooper L.J. A transposon and transposase system for human application. Mol. Ther. 2010, 18:674-683.
10. Collier L.S., Adams D.J., Hackett C.S., Bendzick L.E., Akagi K., Davies M.N., Diers M.D., Rodriguez F.J., Bender A.M., Tieu C., Matise I., Dupuy A.J., Copeland N.G., Jenkins N.A., Hodgson J.G., Weiss W.A., Jenkins R.B., Largaespada D.A. Whole-body sleeping beauty mutagenesis can cause penetrant leukemia/lymphoma and rare high-grade glioma without associated embryonic lethality. Cancer Res. 2009, 69:8429-8437.
11. Geurts A.M., Yang Y., Clark K.J., Liu G., Cui Z., Dupuy A.J., Bell J.B., Largaespada D.A., Hackett P.B. Gene transfer into genomes of human cells by the sleeping beauty transposon system. Mol. Ther. 2003, 8:108-117.
12. Soriano P. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat. Genet. 1999, 21:70-71.
13. Dupuy A.J., Rogers L.M., Kim J., Nannapaneni K., Starr T.K., Liu P., Largaespada D.A., Scheetz T.E., Jenkins N.A., Copeland N.G. A modified sleeping beauty transposon system that can be used to model a wide variety of human cancers in mice. Cancer Res. 2009, 69:8150-8156.
14. Rahrmann E.P., Collier L.S., Knutson T.P., Doyal M.E., Kuslak S.L., Green L.E., Malinowski R.L., Roethe L., Akagi K., Waknitz M., Huang W., Largaespada D.A., Marker P.C. Identification of PDE4D as a proliferation promoting factor in prostate cancer using a Sleeping Beauty transposon-based somatic mutagenesis screen. Cancer Res. 2009, 69:4388-4397.
15. Keng V.W., Villanueva A., Chiang D.Y., Dupuy A.J., Ryan B.J., Matise I., Silverstein K.A., Sarver A., Starr T.K., Akagi K., Tessarollo L., Collier L.S., Powers S., Lowe S.W., Jenkins N.A., Copeland N.G., Llovet J.M., Largaespada D.A. A conditional transposon-based insertional mutagenesis screen for genes associated with mouse hepatocellular carcinoma. Nat. Biotechnol. 2009, 27:264-274.
16. Leenders M.W., Nijkamp M.W., Borel Rinkes I.H. Mouse models in liver cancer research: a review of current literature. World J. Gastroenterol. 2008, 14:6915-6923.
17. Starr T.K., Allaei R., Silverstein K.A., Staggs R.A., Sarver A.L., Bergemann T.L., Gupta M., O'Sullivan M.G., Matise I., Dupuy A.J., Collier L.S., Powers S., Oberg A.L., Asmann Y.W., Thibodeau S.N., Tessarollo L., Copeland N.G., Jenkins N.A., Cormier R.T., Largaespada D.A. A transposon-based genetic screen in mice identifies genes altered in colorectal cancer. Science 2009, 323:1747-1750.
18. Starr T.K., Scott P.M., Marsh B.M., Zhao L., Than B.L., O'Sullivan M.G., Sarver A.L., Dupuy A.J., Largaespada D.A., Cormier R.T. A Sleeping Beauty transposon-mediated screen identifies murine susceptibility genes for adenomatous polyposis coli (Apc)-dependent intestinal tumorigenesis. Proc. Natl. Acad. Sci. USA 2011, 108:5765-5770.
19. Moser A.R., Pitot H.C., Dove W.F. A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 1990, 247:322-324.
20. Dietrich W.F., Lander E.S., Smith J.S., Moser A.R., Gould K.A., Luongo C., Borenstein N., Dove W. Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse. Cell 1993, 75:631-639.
21. Berquam-Vrieze K.E., Nannanpaneni K., Brett B.T., Holmfeldt L., Ma J., Zagorodna O., Jenkins N.A., Copeland N.G., Meyerholz D.K., Knudson C.M., Mullighan C.G., Scheetz T.E., Dupuy A.J. Cell of origin strongly influences genetic selection in mouse models of T-ALL. Blood 2011, 118:4646-4656.
22. de Boer J., Williams A., Skavdis G., Harker N., Coles M., Tolaini M., Norton T., Williams K., Roderick K., Potocnik A.J., Kioussis D. Transgenic mice with hematopoietic and lymphoid specific expression of Cre. Eur. J. Immunol. 2003, 33:314-325.
23. Lee P.P., Fitzpatrick D.R., Beard C., Jessup H.K., Lehar S., Makar K.W., Perez-Melgosa M., Sweetser M.T., Schlissel M.S., Nguyen S., Cherry S.R., Tsai J.H., Tucker S.M., Weaver W.M., Kelso A., Jaenisch R., Wilson C.B. A critical role for Dnmt1 and DNA methylation in T cell development, function, and survival. Immunity 2001, 15:763-774.
24. Niwa H., Yamamura K., Miyazaki J. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 1991, 108:193-199.
25. Rad R., Rad L., Wang W., Cadinanos J., Vassiliou G., Rice S., Campos L.S., Yusa K., Banerjee R., Li M.A., de la Rosa J., Strong A., Lu D., Ellis P., Conte N., Yang F.T., Liu P., Bradley A. PiggyBac transposon mutagenesis: a tool for cancer gene discovery in mice. Science 2010, 330:1104-1107.
26. Marcucci G., Haferlach T., Dohner H. Molecular genetics of adult acute myeloid leukemia prognostic and therapeutic implications. J. Clin. Oncol. 2011, 29:475-486.
27. Kuhn R., Schwenk F., Aguet M., Rajewsky K. Inducible gene targeting in mice. Science 1995, 269:1427-1429.
28. Vassiliou G.S., Cooper J.L., Rad R., Li J., Rice S., Uren A., Rad L., Ellis P., Andrews R., Banerjee R., Grove C., Wang W., Liu P., Wright P., Arends M., Bradley A. Mutant nucleophosmin and cooperating pathways drive leukemia initiation and progression in mice. Nat. Genet. 2011, 43:470-475.
29. Voisin V., Barat C., Hoang T., Rassart E. Novel insights into the pathogenesis of the Graffi murine leukemia retrovirus. J. Virol. 2006, 80:4026-4037.
30. Harrison C.J., Haas O., Harbott J., Biondi A., Stanulla M., Trka J., Izraeli S. Detection of prognostically relevant genetic abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: recommendations from the Biology and Diagnosis Committee of the International Berlin-Frankfurt-Munster study group. Br. J. Haematol. 2010, 151:132-142.
31. van der Weyden L., Giotopoulos G., Rust A.G., Matheson L.S., van Delft F.W., Kong J., Corcoran A.E., Greaves M.F., Mullighan C.G., Huntly B.J., Adams D.J. Modeling the evolution of ETV6-RUNX1-induced B-cell precursor acute lymphoblastic leukemia in mice. Blood 2011, 118:1041-1051.
32. Yant S.R., Huang Y., Akache B., Kay M.A. Site-directed transposon integration in human cells. Nucleic Acids Res. 2007, 35:e50.
33. Largaespada D.A., Collier L.S. Transposon-mediated mutagenesis in somatic cells: identification of transposon-genomic DNA junctions. Methods Mol. Biol. 2008, 435:95-108.
34. Brett B.T., Berquam-Vrieze K.E., Nannapaneni K., Huang J., Scheetz T.E., Dupuy A.J. Novel molecular and computational methods improve the accuracy of insertion site analysis in sleeping beauty-induced tumors. PLoS One 2011, 6:e24668.
35. Koudijs M.J., Klijn C., van der Weyden L., Kool J., Ten Hoeve J., Sie D., Prasetyanti P.R., Schut E., Kas S., Whipp T., Cuppen E., Wessels L., Adams D.J., Jonkers J. High-throughput semi-quantitative analysis of insertional mutations in heterogeneous tumors. Genome. Res. 2011.
36. Iliopoulos D., Drosatos K., Hiyama Y., Goldberg I.J., Zannis V.I. MicroRNA-370 controls the expression of microRNA-122 and Cpt1alpha and affects lipid metabolism. J. Lipid Res. 2010, 51:1513-1523.
37. Mattison J., Kool J., Uren A.G., de Ridder J., Wessels L., Jonkers J., Bignell G.R., Butler A., Rust A.G., Brosch M., Wilson C.H., van der Weyden L., Largaespada D.A., Stratton M.R., Futreal P.A., van Lohuizen M., Berns A., Collier L.S., Hubbard T., Adams D.J. Novel candidate cancer genes identified by a large-scale cross-species comparative oncogenomics approach. Cancer Res. 2010, 70:883-895.
38. Lu B., Geurts A.M., Poirier C., Petit D.C., Harrison W., Overbeek P.A., Bishop C.E. Generation of rat mutants using a coat color-tagged Sleeping Beauty transposon system. Mamm. Genome 2007, 18:338-346.
39. McGrail M., Hatler J.M., Kuang X., Liao H.K., Nannapaneni K., Noack Watt K.E., Uhl J.D., Largaespada D.A., Vollbrecht E., Scheetz T.E., Dupuy A.J., Hostetter J.M., Essner J.J. Somatic mutagenesis with a sleeping beauty transposon system leads to solid tumor formation in zebrafish. PLoS One 2011, 6:e18826.
40. Weng A.P., Millholland J.M., Yashiro-Ohtani Y., Arcangeli M.L., Lau A., Wai C., Del Bianco C., Rodriguez C.G., Sai H., Tobias J., Li Y., Wolfe M.S., Shachaf C., Felsher D., Blacklow S.C., Pear W.S., Aster J.C. c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia/lymphoma. Genes Dev. 2006, 20:2096-2109.
41. Whittaker S., Marais R., Zhu A.X. The role of signaling pathways in the development and treatment of hepatocellular carcinoma. Oncogene 2010, 29:4989-5005.
42. Fearon E.R. Molecular genetics of colorectal cancer. Annu. Rev. Pathol. 2011, 6:479-507.
43. Parkin B., Ouillette P., Wang Y., Liu Y., Wright W., Roulston D., Purkayastha A., Dressel A., Karp J., Bockenstedt P., Al-Zoubi A., Talpaz M., Kujawski L., Shedden K., Shakhan S., Li C., Erba H., Malek S.N. NF1 inactivation in adult acute myelogenous leukemia. Clin. Cancer Res. 2010, 16:4135-4147.
44. Lanza F., Rigolin G.M., Castagnari B., Moretti S., Castoldi G. Potential clinical applications of rhGM-CSF in acute myeloid leukemia based on its biologic activity and receptor interaction. Haematologica 1997, 82:239-245.
45. Soler G., Radford-Weiss I., Ben-Abdelali R., Mahlaoui N., Ponceau J.F., Macintyre E.A., Vekemans M., Bernard O.A., Romana S.P. Fusion of ZMIZ1 to ABL1 in a B-cell acute lymphoblastic leukaemia with a t(9; 10)(q34; q22.3) translocation. Leukemia 2008, 22:1278-1280.
46. Bonazzi V.F., Irwin D., Hayward N.K. Identification of candidate tumor suppressor genes inactivated by promoter methylation in melanoma. Genes Chromosomes Cancer 2009, 48:10-21.
47. Bender A.M., Collier L.S., Rodriguez F.J., Tieu C., Larson J.D., Halder C., Mahlum E., Kollmeyer T.M., Akagi K., Sarkar G., Largaespada D.A., Jenkins R.B. Sleeping beauty-mediated somatic mutagenesis implicates CSF1 in the formation of high-grade astrocytomas. Cancer Res. 2010, 70:3557-3565.
48. Meng F., Wehbe-Janek H., Henson R., Smith H., Patel T. Epigenetic regulation of microRNA-370 by interleukin-6 in malignant human cholangiocytes. Oncogene 2008, 27:378-386.